Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001753926-23-000378
Filing Date
2023-04-03
Accepted
2023-04-03 16:05:54
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B3 g083468_424b3.htm 424B3 1344268
2 GRAPHIC img001.jpg GRAPHIC 39651
3 GRAPHIC img002.jpg GRAPHIC 34010
4 GRAPHIC img003.jpg GRAPHIC 26781
5 GRAPHIC img004.jpg GRAPHIC 35135
6 GRAPHIC image_001.jpg GRAPHIC 3120
  Complete submission text file 0001753926-23-000378.txt   1536903
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-266397 | Film No.: 23792624
SIC: 2834 Pharmaceutical Preparations